Dashboard
Manage Tickers

MRK


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

mrna-technology-promises-to-make-a-long-time-coming-turning-point-in-cancer-treatment
mRNA Technology Promises To Make A Long-Ti...
07/02/2024 17:38:18

The medical and pharmaceutical community continues to embrace emerging technologies, beginning with mRNA that rose to fame duri...

insights-into-merck-amp-cos-performance-versus-peers-in-pharmaceuticals-sector
Insights Into Merck & Co's Performance...
07/02/2024 15:00:39

5-biggest-winners-5-biggest-losers-from-dow-jones-industrial-average-in-first-half-2024
5 Biggest Winners, 5 Biggest Losers From D...
07/01/2024 22:38:43

Ten of the Dow Jones Industrial Average stocks were up double digit percentage in the first half of 2024. A look at the best an...

whats-going-on-with-merck-stock-on-monday
What's Going On With Merck Stock On Monday?
07/01/2024 17:26:41

Merck secures exclusive global rights to develop and commercialize opevesostat (MK-5684/ODM-208) for hormone-dependent cancers....

market-whales-and-their-recent-bets-on-mrk-options
Market Whales and Their Recent Bets on MRK...
07/01/2024 15:47:10

merck-and-orion-announce-mutual-exercise-of-option-to-convert-opevesostat-co-commercialization-agreement-into-an-exclusive-global-license-for-merck-orion-now-eligible-for-development-milestones-up-to-30m-regulatory-milestones-up-to-625m-and-sales-milestones-up-to-975m
Merck And Orion Announce Mutual Exercise O...
07/01/2024 12:20:16

whats-going-on-with-merck-stock-on-friday
What's Going On With Merck Stock On Friday?
06/28/2024 12:39:32

The CDC's Advisory Committee on Immunization Practices recommends Merck's Capvaxive for adults 65+ and certain at-risk ...

the-committee-for-medicinal-products-for-human-use-of-the-european-medicines-agency-recommended-the-approval-of-mercks-winrevair-sotatercept-combined-with-other-pulmonary-arterial-hypertension-pah-therapies-for-pah-in-adult-patients
The Committee For Medicinal Products For H...
06/28/2024 11:02:41

, European Commission's Decision Is Expected In Q3 

Core News & Articles
Merck's Pneumonia Shot Recommended For Hea...
06/27/2024 20:54:35

- Bloomberg

a-closer-look-at-merck--cos-options-market-dynamics
A Closer Look at Merck & Co's Options Mark...
06/27/2024 19:49:25

Core News & Articles
CDC's ACIP Unanimously Votes To Add Merck ...
06/27/2024 19:40:39

- Reuters

fda-declines-to-approve-merck-daiichi-sankyo-partnered-lung-cancer-drug
FDA Declines To Approve Merck-Daiichi Sank...
06/27/2024 14:13:16

The FDA issued a Complete Response Letter for Daiichi Sankyo and Merck's BLA for patritumab deruxtecan targeting EGFR-mutat...

reported-earlier-fda-issues-complete-response-letter-for-daiichi-sankyo-and-mercks-lung-cancer-treatment-patritumab-deruxtecan-approval-delayed-by-fda-due-to-third-party-manufacturing-concerns
Reported Earlier, FDA Issues Complete Resp...
06/27/2024 07:13:05

The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the Biologics License Application (...

beating-cancer-is-still-an-everything-but-easy-challenge-that-pharmaceutical-companies-cannot-solve-overnight
Beating Cancer Is Still An Everything-But-...
06/26/2024 15:29:20

On Tuesday, Merck Group revealed an unexpected decision to end a Phase III trial of its cancer drug Xevinapant. This move threa...

merck--companys-merck-animal-health-received-approval-of-nobivac-nxt-canine-flu-h3n2-from-us-dept-of-agriculture
Merck & Company's Merck Animal Health Rece...
06/25/2024 20:06:30

Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease

analyst-sees-keros-therapeutics-as-next-acceleron-set-for-major-biotech-growth
Analyst Sees Keros Therapeutics As Next Ac...
06/25/2024 18:43:19

Keros Therapeutics is advancing novel therapies for hematological and cardiopulmonary disorders via TGF-β signaling regulation....

gossamer-bios-clean-safety-profile-differentiates-it-from-merck-analyst-says
Gossamer Bio's Clean Safety Profile Differ...
06/25/2024 18:39:14

Oppenheimer initiated coverage on Gossamer Bio, highlighting seralutinib's clean long-term safety profile for pulmonary art...

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
06/25/2024 17:35:24

Core News & Articles
CORRECTION: Merck KGaA Ticker Is "MKGAF"
06/24/2024 17:06:47

5-biotech-stocks-with-key-catalysts-this-week-merck-intellia-verona-and-more
5 Biotech Stocks With Key Catalysts This W...
06/24/2024 08:51:47

Biotech investing is risk-fraught but the returns could be staggering if one chooses to take the educated approach.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)